Clinical Trials Browser

OTHER × Lymphoma, Non-Hodgkin × Brentuximab Vedotin × Clear all

NCT01703949 2025-06-11

Brentuximab Vedotin With or Without Nivolumab in Treating Patients With Relapsed or Refractory CD30+ Lymphoma

Phase 2 Active not recruiting

Hodgkin Disease, Lymphoma, Non-Hodgkin

NCT02280785 2018-09-06

BRAN

Phase 2 Completed

Lymphoma, Non-Hodgkin

NCT02408042 2017-06-27

Study of Pembrolizumab With Chemotherapy in Patients With Advanced Lymphoma (PembroHeme)

Phase 1/2 Withdrawn

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin

NCT01396070 2017-04-05

Brentuximab Vedotin (SGN-35) in Patients With Mycosis Fungoides With Variable CD30 Expression Level

Phase 2 Completed

36 enrolled 13 charts

DermatologicLymphoid

Lymphoma, Non-Hodgkin, Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous